Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1MTJ
|
||||
| Drug Name |
(S)-N-(cyanomethyl)-4-methyl-2-((S)-2,2,2-trifluoro-1-phenylethylamino)pentanamide
|
||||
| Synonyms |
CHEMBL204276
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H20F3N3O
|
||||
| Canonical SMILES |
CC(C)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NCC#N
|
||||
| InChI |
InChI=1S/C16H20F3N3O/c1-11(2)10-13(15(23)21-9-8-20)22-14(16(17,18)19)12-6-4-3-5-7-12/h3-7,11,13-14,22H,9-10H2,1-2H3,(H,21,23)/t13-,14-/m0/s1
|
||||
| InChIKey |
RPWHXFWFWHAXEI-KBPBESRZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.